JAM
PFE icon

Jolley Asset Management’s Pfizer PFE Stock Holding History

Jolley Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$4.11M Sell
132,696
-368
-0.3% -$12.5K 3.16% 5
2019
Q4 		$4.95M Sell
133,064
-13,883
-9% -$495K 2.81% 11
2019
Q3 		$5.01M Buy
146,947
+11,138
+8% +$405K 3.26% 7
2019
Q2 		$5.58M Sell
135,809
-418
-0.3% -$16.6K 3.58% 1
2019
Q1 		$5.49M Buy
136,227
+1,378
+1% +$55.2K 3.97% 1
2018
Q4 		$5.58M Buy
134,849
+4,120
+3% +$171K 4.28% 1
2018
Q3 		$5.47M Sell
130,729
-791
-0.6% -$30.5K 3.67% 3
2018
Q2 		$4.53M Sell
131,520
-5,786
-4% -$198K 3.03% 5
2018
Q1 		$4.62M Buy
137,306
+7,226
+6% +$248K 2.8% 10
2017
Q4 		$4.47M Buy
130,080
+113
+0.1% +$3.85K 2.84% 14
2017
Q3 		$4.4M Sell
129,967
-940
-0.7% -$30.2K 2.99% 9
2017
Q2 		$4.17M Buy
130,907
+2,302
+2% +$72.6K 2.92% 10
2017
Q1 		$4.17M Buy
128,605
+214
+0.2% +$6.75K 3% 13
2016
Q4 		$3.96M Sell
128,391
-145
-0.1% -$4.43K 2.84% 15
2016
Q3 		$4.13M Sell
128,536
-169
-0.1% -$5.65K 3.34% 6
2016
Q2 		$4.3M Sell
128,705
-383
-0.3% -$12.2K 3.46% 3
2016
Q1 		$3.63M Buy
129,088
+4,767
+4% +$136K 3.3% 8
2015
Q4 		$3.81M Sell
124,321
-1,419
-1% -$44.6K 3.62% 4
2015
Q3 		$3.75M Sell
125,740
-973
-0.8% -$31.2K 3.8% 2
2015
Q2 		$4.03M Sell
126,713
-1,755
-1% -$57.2K 3.66% 2
2015
Q1 		$4.24M Sell
128,468
-1,386
-1% -$44.1K 3.52% 1
2014
Q4 		$3.84M Buy
129,854
+576
+0.4% +$16.5K 3.18% 10
2014
Q3 		$3.63M Sell
129,278
-1,391
-1% -$39K 2.92% 15
2014
Q2 		$3.68M Sell
130,669
-2,475
-2% -$70.6K 2.7% 18
2014
Q1 		$4.06M Sell
133,144
-3,138
-2% -$93.6K 3.02% 8
2013
Q4 		$3.96M Sell
136,282
-925
-0.7% -$26.9K 3.12% 9
2013
Q3 		$3.74M Sell
137,207
-5,115
-4% -$139K 3.12% 6
2013
Q2 		$3.78M Buy
+142,322
New +$3.93M 3.06% 9

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Jolley Asset Management's PFE Position: Q1 2020 in Review

Jolley Asset Management reduced its Pfizer (PFE) stake by 0.28% in Q1 2020, selling an estimated $12.5K and leaving 132,696 shares worth $4.11M. The position accounts for 3.16% of the portfolio, ranked #5.

Jolley Asset Management first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.58M in Q4 2018. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Jolley Asset Management held 132,696 shares of Pfizer worth $4.11M as of Q1 2020.
  • Jolley Asset Management sold 368 Pfizer shares in Q1 2020, an estimated $12.5K.
  • Pfizer made up 3.16% of Jolley Asset Management's portfolio in Q1 2020, its #5 holding.
  • Jolley Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • Jolley Asset Management's Pfizer position peaked at $5.58M in Q4 2018.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Jolley Asset Management's 13F filing for Q1 2020, filed 15 Apr 2020.